{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:53:59Z","timestamp":1792634039543,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.metabol.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T04:16:10Z","timestamp":1407039370000},"page":"146-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Leptin treatment: Facts and expectations"],"prefix":"10.1016","volume":"64","author":[{"given":"Gilberto","family":"Paz-Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio A.","family":"Mastronardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Licinio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.metabol.2014.07.014_bb0005","first-page":"242S","article-title":"Adipose tissue as an endocrine organ","volume":"14","author":"Ahima","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2014.07.014_bb0010","first-page":"194","article-title":"Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain","volume":"61","author":"Boguszewski","year":"2010","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0015","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0020","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1111\/j.1467-789X.2010.00840.x","article-title":"Ten years of leptin replacement therapy","volume":"12","author":"Paz-Filho","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2014.07.014_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.07.014_bb0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","volume":"269","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.07.014_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.07.014_bb0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.07.014_bb0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM199909163411211","article-title":"The role of leptin in human physiology","volume":"341","author":"Rosenbaum","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.07.014_bb0050","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40265-013-0074-7","article-title":"Metreleptin: first global approval","volume":"73","author":"Chou","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2014.07.014_bb0055","series-title":"Myalept Package Insert","author":"Bristol-Myers Squibb","year":"2014"},{"key":"10.1016\/j.metabol.2014.07.014_bb0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","article-title":"Clinical effects of long-term metreleptin treatment in patients with lipodystrophy","volume":"17","author":"Chan","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2014.07.014_bb0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2169\/internalmedicine.53.1713","article-title":"Primary intestinal follicular lymphoma and premature atherosclerosis in a japanese diabetic patient with atypical familial partial lipodystrophy","volume":"53","author":"Iwanishi","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.metabol.2014.07.014_bb0070","article-title":"Acquired generalized lipodystrophy associated with peripheral T-cell lymphoma with cutaneous infiltration","author":"Aslam","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0080","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.07.014_bb0085","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","article-title":"Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin","volume":"162","author":"Beltrand","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0090","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.3945\/ajcn.2008.26788C","article-title":"Leptin: a pivotal regulator of human energy homeostasis","volume":"89","author":"Farooqi","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2014.07.014_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/17477166.2011.608431","article-title":"Leptin deficiency and leptin gene mutations in obese children from Pakistan","volume":"6","author":"Fatima","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.metabol.2014.07.014_bb0100","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1210\/jc.2004-0376","article-title":"Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy","volume":"89","author":"Gibson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.07.014_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymgme.2012.03.001","article-title":"High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families","volume":"106","author":"Saeed","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ymgme.2009.04.002","article-title":"A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient","volume":"97","author":"Mazen","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0120","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2009-2466","article-title":"A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness","volume":"95","author":"Fischer-Posovszky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0125","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0130","doi-asserted-by":"crossref","first-page":"e3098","DOI":"10.1371\/journal.pone.0003098","article-title":"Leptin replacement improves cognitive development","volume":"3","author":"Paz-Filho","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.07.014_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity","volume":"18","author":"Strobel","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2014.07.014_bb0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0028-1082048","article-title":"Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment","volume":"41","author":"Andreev","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2014.07.014_bb0145","doi-asserted-by":"crossref","first-page":"18276","DOI":"10.1073\/pnas.0706481104","article-title":"Leptin replacement alters brain response to food cues in genetically leptin-deficient adults","volume":"104","author":"Baicy","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.07.014_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12311-012-0360-z","article-title":"Effects of leptin deficiency and replacement on cerebellar response to food-related cues","volume":"12","author":"Berman","year":"2013","journal-title":"Cerebellum"},{"key":"10.1016\/j.metabol.2014.07.014_bb0155","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1144599","article-title":"Leptin regulates striatal regions and human eating behavior","volume":"317","author":"Farooqi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.07.014_bb0160","doi-asserted-by":"crossref","first-page":"e65893","DOI":"10.1371\/journal.pone.0065893","article-title":"Long-term stabilization effects of leptin on brain functions in a leptin-deficient patient","volume":"8","author":"Frank","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.07.014_bb0165","doi-asserted-by":"crossref","first-page":"E1283","DOI":"10.1210\/jc.2010-2713","article-title":"Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas","volume":"96","author":"Frank","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/jc.2009-1739","article-title":"Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients","volume":"95","author":"Galgani","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mp.2011.156","article-title":"Dopamine D2\/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement","volume":"17","author":"Ishibashi","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.07.014_bb0185","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.0308767101","article-title":"Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults","volume":"101","author":"Licinio","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.07.014_bb0190","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.ijo.0803703","article-title":"Effects of leptin replacement on macro- and micronutrient preferences","volume":"31","author":"Licinio","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2014.07.014_bb0195","doi-asserted-by":"crossref","first-page":"E1212","DOI":"10.1210\/jc.2011-0314","article-title":"Short-term plasticity of gray matter associated with leptin deficiency and replacement","volume":"96","author":"London","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0200","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2004-1979","article-title":"Effect of leptin replacement on brain structure in genetically leptin-deficient adults","volume":"90","author":"Matochik","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-6614-2-11","article-title":"Congenital leptin deficiency and thyroid function","volume":"2","author":"Paz-Filho","year":"2009","journal-title":"Thyroid Res"},{"key":"10.1016\/j.metabol.2014.07.014_bb0210","doi-asserted-by":"crossref","first-page":"E1401","DOI":"10.1152\/ajpendo.90450.2008","article-title":"Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients","volume":"295","author":"Paz-Filho","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0028-1082037","article-title":"Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects","volume":"41","author":"Paz-Filho","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2014.07.014_bb0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0028-1082052","article-title":"Effects of leptin on lipid metabolism","volume":"40","author":"Paz-Filho","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2014.07.014_bb0225","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1515\/JPEM.2009.22.11.1069","article-title":"Cellular immunity before and after leptin replacement therapy","volume":"22","author":"Paz-Filho","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0230","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000348541","article-title":"Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl","volume":"79","author":"von Schnurbein","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.metabol.2014.07.014_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000336003","article-title":"Leptin substitution results in the induction of menstrual cycles in an adolescent with leptin deficiency and hypogonadotropic hypogonadism","volume":"77","author":"von Schnurbein","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.metabol.2014.07.014_bb0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.appet.2005.01.002","article-title":"Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy","volume":"45","author":"Williamson","year":"2005","journal-title":"Appetite"},{"key":"10.1016\/j.metabol.2014.07.014_bb0245","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1073\/pnas.95.5.2541","article-title":"Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women","volume":"95","author":"Licinio","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.07.014_bb0250","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2011.04.008","article-title":"Effects of leptin and adiponectin on pancreatic beta-cell function","volume":"60","author":"Lee","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.metabol.2012.08.012","article-title":"The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review","volume":"62","author":"Michalakis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0260","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","article-title":"Adipocytokines in relation to cardiovascular disease","volume":"62","author":"Van de Voorde","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0265","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1161\/CIRCULATIONAHA.107.741645","article-title":"Leptin and cardiovascular disease: response to therapeutic interventions","volume":"117","author":"Koh","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.07.014_bb0270","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.metabol.2012.05.001","article-title":"Central leptin and insulin administration modulates serum cytokine- and lipoprotein-related markers","volume":"61","author":"Burgos-Ramos","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0275","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1590\/S0004-27302012000900001","article-title":"Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications","volume":"56","author":"Paz-Filho","year":"2012","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0280","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1210\/en.2013-1622","article-title":"IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob\/ob mice","volume":"155","author":"Neumann","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.07.014_bb0285","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1210\/jcem.86.7.7644","article-title":"Synchronicity of frequently sampled TSH and leptin concentrations in healthy adults and leptin deficient subjects: evidence for possible partial TSH regulation by leptin in humans","volume":"86","author":"Mantzoros","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/17446651.2014.894877","article-title":"Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy","volume":"9","author":"Simha","year":"2014","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0295","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2013.04.014","article-title":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","volume":"62","author":"Paruthi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0300","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.metabol.2012.03.013","article-title":"Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome","volume":"61","author":"Sekhar","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0305","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.metabol.2012.04.013","article-title":"Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials","volume":"61","author":"Foo","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(05)66830-4","article-title":"Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa","volume":"366","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.07.014_bb0315","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.07.014_bb0320","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1073\/pnas.1015674108","article-title":"Leptin is an effective treatment for hypothalamic amenorrhea","volume":"108","author":"Chou","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.07.014_bb0325","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.metabol.2011.05.016","article-title":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","volume":"60","author":"Sienkiewicz","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0330","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1073\/pnas.1214554110","article-title":"Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia","volume":"110","author":"Matarese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.07.014_bb0335","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1007\/s00125-011-2201-x","article-title":"Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans","volume":"54","author":"Aronis","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.07.014_bb0340","doi-asserted-by":"crossref","first-page":"R566","DOI":"10.1152\/ajpregu.00180.2013","article-title":"Selective leptin resistance revisited","volume":"305","author":"Mark","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0345","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.07.014_bb0350","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1463-1326.2005.00468.x","article-title":"Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial","volume":"7","author":"Zelissen","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0355","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/oby.20433","article-title":"Randomized double-blind placebo-controlled study of leptin administration after gastric bypass","volume":"21","author":"Korner","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2014.07.014_bb0360","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/db10-1791","article-title":"Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance","volume":"60","author":"Moon","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.07.014_bb0365","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.metabol.2011.02.010","article-title":"Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss","volume":"60","author":"Conroy","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.07.014_bb0370","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2014.07.014_bb0375","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/psc.2408","article-title":"Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21","volume":"18","author":"Muller","year":"2012","journal-title":"J Pept Sci"},{"key":"10.1016\/j.metabol.2014.07.014_bb0380","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1590\/S0004-27302009000900005","article-title":"Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome","volume":"53","author":"Paz-Filho","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0385","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35102112","article-title":"Partial leptin deficiency and human adiposity","volume":"414","author":"Farooqi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.07.014_bb0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/08916934.2010.482116","article-title":"Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats","volume":"44","author":"Kruger","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.metabol.2014.07.014_bb0395","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrd3757","article-title":"Leptin revisited: its mechanism of action and potential for treating diabetes","volume":"11","author":"Coppari","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2014.07.014_bb0400","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2337\/db10-1302","article-title":"Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes","volume":"60","author":"Mittendorfer","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.07.014_bb0405","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2014.07.014_bb0410","doi-asserted-by":"crossref","first-page":"E1749","DOI":"10.1210\/jc.2013-2317","article-title":"Metreleptin improves blood glucose in patients with insulin receptor mutations","volume":"98","author":"Brown","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0415","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","volume":"41","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2014.07.014_bb0420","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.coph.2007.10.010","article-title":"The leptin hypothesis of depression: a potential link between mood disorders and obesity?","volume":"7","author":"Lu","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.metabol.2014.07.014_bb0425","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/mp.2011.161","article-title":"Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta\/beta-catenin signaling","volume":"17","author":"Garza","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.07.014_bb0430","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.07.014_bb0435","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease","volume":"19","author":"Greco","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2014.07.014_bb0440","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-1241.2010.02536.x","article-title":"The procognitive effects of leptin in the brain and their clinical implications","volume":"64","author":"Paz-Filho","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.metabol.2014.07.014_bb0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cmet.2012.01.002","article-title":"Challenges and opportunities of defining clinical leptin resistance","volume":"15","author":"Myers","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0450","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2012.11.003","article-title":"Neuroinflammation and neurodegeneration in overnutrition-induced diseases","volume":"24","author":"Cai","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0455","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI59660","article-title":"Obesity is associated with hypothalamic injury in rodents and humans","volume":"122","author":"Thaler","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.07.014_bb0460","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2009.08.013","article-title":"MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity","volume":"10","author":"Kleinridders","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.07.014_bb0465","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2008.07.043","article-title":"Hypothalamic IKKbeta\/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity","volume":"135","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2014.07.014_bb0470","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/db09-1024","article-title":"Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis","volume":"59","author":"Reed","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.07.014_bb0475","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/db11-0390","article-title":"Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver","volume":"61","author":"Milanski","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.07.014_bb0480","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/emboj.2013.25","article-title":"pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location","volume":"32","author":"Lu","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2014.07.014_bb0485","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:07:43Z","timestamp":1758427663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0026049514002340"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.07.014","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin treatment: Facts and expectations","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}